Treatment of cats with feline infectious peritonitis |
| |
| Authors: | Hartmann Katrin Ritz Susanne |
| |
| Institution: | aDepartment of Small Animal Internal Medicine, LMU University of Munich, Veterinaerstrasse 13, 80539 Muenchen, Germany |
| |
| Abstract: | Feline infectious peritonitis (FIP) infection resulting in clinical signs is invariably fatal despite clinical intervention. As FIP is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression but do not produce a cure. In nearly every published case report of attempted therapy for clinical FIP, glucocorticoids have been used; there are, however, no controlled studies that evaluate the effect of glucocorticoids as a therapy for FIP. Some veterinarians prescribe immune modulators to treat cats with FIP with no documented controlled evidence of efficacy. It has been suggested that these agents may benefit infected animals by restoring compromised immune function, thereby allowing the patient to control viral burden and recover from clinical signs. However, a non-specific stimulation of the immune system may be contraindicated as clinical signs develop and progress as a result of an immune-mediated response to the mutated FCoV. |
| |
| Keywords: | Feline infectious peritonitis Cat Treatment Review |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
